Furthermore, ROCKi-treated tumors had reduced p-MLC2 and lower numbers of CD206+ macrophages (total number of F4/80+ macrophages were unaffected), which could also contribute to reduced tumor growth in an extrinsic manner. This evidence concerns the gene MYL9 and neoplasm.